Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Handa, Ankur
- To Assess Hepatic Function (LFTs), Serum Iron and TIBC in Thalassemia Major Children
Abstract Views :231 |
PDF Views:0
Authors
Affiliations
1 Department of Pediatrics, Govt. Medical College Patiala, IN
2 Department Of Biochemistry, Govt. Medical College Patiala, IN
1 Department of Pediatrics, Govt. Medical College Patiala, IN
2 Department Of Biochemistry, Govt. Medical College Patiala, IN
Source
The Indian Practitioner, Vol 71, No 3 (2018), Pagination: 29-33Abstract
The present study is a type of case control study. The objective of the study is to determine liver function (LFTs), S.Iron and TIBC in 100 blood transfused, Beta Thalassemic children attending thalassemia unit, Rajindra Hospital, Patiala. Iron overload as suggested by increase in S. Iron and decreased TIBC levels leads to liver dysfunction manifested by deranged liver function tests in thalassemia major children.Keywords
Thalassemia, Hemoglobinopathies, TIBC.
References
- Kremastinos DT, Tsiapras DP, Kostopoulou AG, Hamodraka ES, Chaidaroglou AS, Kapsali ED et al. NTpro BNP levels and diastolic dysfunction in beta-thalassaemia major patients. Eur J Heart Fail. 2007;9:531–6.
- Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2.
- Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous betathalassemia. N Engl J Med. 1994;331:574 –8.
- World population data sheet. Washington DC: Population Reference Bureau; 2009.
- Christianson A, Howson CP, Modell B. March of Dimes global report on birth defects. White Plains: March of Dimes Birth Defects Foundation; 2006.
- WHO (1989) Guidelines for the control of haemoglobin disorders: report of the VIth Annual Meeting of the WHO Working Group on Haemoglobinopathies, Cagliari, Sardinia, 8–9 April, 1989. Geneva, World Health Organization (unpublished document WHO/HDP/WG/ HA/89.2)
- Weatherall DJ, Clegg JB, Thalassaemia - a global public health problem. Nat Med 1996:2,847-9.
- Firkin F, Chesterman C, Penington D, Rush B. de Gruchy’s Clinical Hematology in Medical Practice. Blackwell, Australia. 1996; 5:137.
- Olivieri NF, Weatherall DJ. Recent progress in the Management of thalassaemia. HKJ Paediatr (New series) 1996; 1: 14-22.
- Higgs DR, Thein SL, Woods WG. The molecular pathology of Thalassaemia. In: Weatherall DJ, Clegg B, eds. The Thalassaemia syndromes. Oxford, England: Blackwell science, 2001;4:133- 91.
- Lehmann H, Carrell RW. Differences between alpha and beta chain mutants of human hemoglobin and between alpha and beta thalassaemia. Possible duplication alpha chain gene. Br. Med J 1968; 4 (5633) 748-50.
- Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusion iron overload. Blood 2003; 102: 17- 24.
- Olivieri NF. The beta thalassaemias. N engl J Med 1999; 341: 99 - 109.
- Hershko C, Konijn AM, Link G. Iron chelators for thalassaemia. Br J Haematol 1998; 101: 399 - 406.
- Olivieri NF, Brittenham GM. Iron- chelating therapy and the treatment of thalassaemia. Blood 1997; 89: 739.
- Win LL, Ni H, Sin S, Naing Z. Extremely High Serum Ferritin Levels Associated With Abnormal Liver Function In Multi-Transfused Patients With Beta Thalassemia Major In Myanmar. The Internet Journal of Hematology. 2013;9: 5-8.
- Ragab SM, Safan MA, Sherif AS. Lipid profiles in β thalassemia children. Menoufia Med J 2014;27:67-72.
- Sultana N, Sadiya S, Rahman MH. Correlation between Serum bilirubin and serum ferritin level in thalassemia patients. Bangladesh. Med Biochem 2011;4(2):6-12
- Asif M, Manzor Z, Farooq MS, Kanwal A, Shaheen U, Munawar SH et al. Correlation between serum ferritin level and liver function tests in thalassemia patients receiving multiple blood transfussions. International Journal of Research in Medical Sciences. Asif M et al. Int J Res Med Sci. 2014;2(3): 988-94.
- Patne AB, Hisalkar PJ, Gaikwad SB, Patil SV. Alterations in antioxidant enzyme status with lipid peroxidationin β thalassemia major patients. Int. J of Pharm and Life Sci. 2012;3(10):1-4
- Saral N, Rathore M, Bohra VD, Gupta M. Diagnostic significance of Liver and Renal function tests (LFT&RFT) in Iron overload in patients with β Thalassemia major. International Journal of Clinical Biochemistry and Research 2015; 2(1):27-32.
- Shams S, Ashtiani MTH, Monajemzadeh M, Koochakzadeh L, Irani H, Jafari F et al. Evaluation of Serum Insulin, Glucose, Lipid Profile, and Liver Function in β-Thalassemia Major Patients and Their Correlation With Iron Overload. Lab Medicine 2010;41(8):486-9.
- Mohammad II, Al-Doski FS. Assessment of Liver Functions in Thalassemia. Tikrit Journal of Pharmaceutical sciences 2012;8(1):87-93.
- Al-Kataan MA, Al- Shakarchi SD. Changes of some Liver Functions Fests with Regular And Irregular Desferroxamine Therapy in Beta-Thalassemia Patients. Zanco J. Med. Sci.2010;14(1):166-9.
- Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with betathalassaemia major and intermedia. Endokrynol Pol. 2012;63(4):260-3
- Bandebuche S, Sagar V, Sontakke A. Serum total Calcium level in patients with Thalassemia. Int J Med Res Rev 2013;1(4):190-4.
- Hagag AA, El-Shanshory MR, El-Enein AAM. Parathyroid function in children with beta thalassemia and correlation with iron load. Adv Pediatr Res 2015;2(3):1-6.
- Trivedi DJ, Sagare A. Assessment of Iron Overload in Homozygous and Heterozygous Beta Thalassemic Children below 5 Years of Age. JKIMSU 2014;3(2):17-22.